Preview Mode Links will not work in preview mode

This Week in Cardiology

May 19, 2023

When to use an ICD, risk stratification for HCM, blending EP and structural cardiology to improve care in post-TAVI patients, and hsTroponins are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. ICD in Patients with NICM

Simple Risk Score Predicts VT in Nonischemic Cardiomyopathy

- Declining Risk of Sudden Death in Heart Failure

- Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

- Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar

- RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure (BRITISH)

II. Risk Stratification in HCM

- Changing Risk Stratification in Hypertrophic Cardiomyopathy?

- NOAH–AFNET 6 trial terminates ahead of time (NOAH AFNET 6 trial)

III. Blending EP and Structural to Improve TAVI Care

- Impact of Right Ventricular Pacing in Patients With TAVR Undergoing Permanent Pacemaker Implantation

IV. Troponins

- Age-Specific Cut-Offs Needed for Cardiac Troponin Tests?

- Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults

- What Is a Normal Troponin Anyway?

- Updating Our Thinking on Troponin Use and Interpretation

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact